Meribank Biotech Co., Ltd (TPEX: 4724)
Health Care · Health Care Providers & Services · TW
NT$8.94
-1.65% today · -48.2% 1Y
Meribank Biotech Co., Ltd (TPEX: 4724) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $26.82M and employs 142 people.
Over the last twelve months the share price has lost 48.2%, trading between 8.47 and 24.75.
Tweenvest scores Meribank Biotech Co., Ltd across four factors: quality 49/100, value 50/100. Its strongest factor is value.
4724 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $26.82M
- Revenue (TTM)
- $15.02M
- P/E
- —
- EPS
- -0.89
- Dividend yield
- —
- Beta (5Y)
- 0.43
- 52-week high
- NT$24.75
- 52-week low
- NT$8.47
- Avg volume (3M)
- —
- Shares outstanding
- 95.98M
- Employees
- 142
- Next earnings
- —
About Meribank Biotech Co., Ltd
Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei City, Taiwan, is a company dedicated to the cultivation, advancement, and banking of mesenchymal stem cells. The firm specializes in the preservation of various cell types, including mesenchymal stem cells sourced from the placenta and umbilical cord, hematopoietic stem cells from cord blood, and diverse immune cells. Additionally, Meribank is involved in developing advanced cellular cryopreservation protocols and provides postpartum nursing services.
- ISIN
- TW0004724000
- Founded
- 2001
- Listed since
- Jun 16, 2023
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $390.11 | +1.37% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.02 | -0.67% |
| McKesson CorporationNYSE: MCK | $100.14B | $858.90 | +2.40% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $429.19 | +5.64% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $400.54 | +1.07% |
| The Cigna GroupNYSE: CI | $73.33B | $277.51 | +1.13% |
| Cencora, Inc.NYSE: COR | $60.69B | $318.04 | +1.06% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $229.51 | +0.46% |
Figures last refreshed Aug 18, 2026.